Implementations by Phenotype

Title Phenotype Institution Algorithm Type Total Cases Total Controlssort descending PPV Sensitivity
NU T2DM PRS implementation Type 2 Diabetes - PRS Evaluation Northwestern University Case, Control
Mayo clinic hearing loss implementation Hearing Loss Mayo Clinic Case, Control
CHOP Part II- RESPONDERS Epilepsy/Antiepileptic drug response algorithm Case Only 85%
GH/UW Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) GH/UW Case Only
DR Marshfield Implementation Diabetic Retinopathy Marshfield Clinic Research Foundation Case, Control 80%, 98% 98%, 86%
MGB Type 1 Diabetes Case, Control
CCHMC Primary Validation Migraine Case Only 92%
PAD Mayo Implementation Peripheral Arterial Disease - 2012 Mayo Clinic Case Only 91% 86%
CHOP Pneumonia Pneumonia- VUMC eMERGE v5.1 CHOP Case, Control
Vanderbilt implementation Clostridium Difficile Colitis Case, Control 100%, 100%
Marshfield SLE Implementation SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria Marshfield Clinic Research Institute Case Only
Validation of ACEi-induced cough algorithm ACE Inhibitor (ACE-I) induced cough Mayo Clinic Case, Control 100%, 96%
Mayo Depression Algorithm Implementation Depression Mayo Clinic Case, Control
CHOP implementation Case 3 Appendicitis Case Only 10 50%
Geisinger AAA Implementation Abdominal Aortic Aneurysm ( AAA ) Geisinger Case, Control 94% 100%
Mayo_T2D_phaseIV_implementation Type 2 Diabetes - PRS Evaluation Mayo Clinic Case Only
CCHMC - PART 1 Epilepsy/Antiepileptic drug response algorithm Cincinnati Children's Hospital Medical Center Case Only 129 86%
CRF_Columbia Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) Columbia University Case Only 2
DR Vanderbilt Implementation Diabetic Retinopathy Vanderbilt University Case, Control 68%, 100%
Warfarin-Columbia Warfarin dose/response Columbia University Case Only
PAD Northwestern Implementation Peripheral Arterial Disease - 2012 Northwestern University Case, Control 95%, 100% 100%, 82%
RA for NU eMERGEseq only population Rheumatoid Arthritis (RA) Northwestern University Case, Control
ADHD Validation (CCHMC) ADHD phenotype algorithm Cincinnati Children's Hospital Medical Center Case, Control 89%, 95%
KPWHRI SLE Implementation SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria KPWHRI Case, Control
NU ACE Inhibitor (ACE-I) induced cough implementation ACE Inhibitor (ACE-I) induced cough Northwestern University The Feinberg School of Medicine Case, Control 100%, 98%

Pages